Also known as آسٹیوپوروسس مینجمنٹ
Internal Medicine Specialist
MBBS, FCPS (Medicine)
Gastroenterologist
M.B.B.S, F.C.P.S (Gastroenterology)
Asthma Specialist
MBBS, MRCP (UK)
Internal Medicine Specialist
M.B.B.S., M.C.P.S. (Family Medicine) Gold Medalist, MRCGP int
Internal Medicine Specialist
M.B.B.S., M.C.P.S. (Family Medicine) Gold Medalist, MRCGP int
Oncologist
M.B.B.S., F.C.P.S., Certified Medical Oncologist/Hematologist
Oncologist
M.B.B.S., F.C.P.S., Certified Medical Oncologist/Hematologist
Diabetologist
M.D (St'Lucia), Diplomate Diabetes
Family Physician
MBBS , Diplomate MD , MSC in Family Medicine (Canada) , Diplomate MD (Masters) in Acute Medicine (UK-South Wales) , Diplomate in Aesthetic Medicine, Cert Cosmetiligist & Aesthetician
Family Physician
MBBS , Diplomate MD , MSC in Family Medicine (Canada) , Diplomate MD (Masters) in Acute Medicine (UK-South Wales) , Diplomate in Aesthetic Medicine, Cert Cosmetiligist & Aesthetician
Internal Medicine Specialist
MBBS, FCPS (Medicine)
Bisphosphonates are used as first-line pharmacologictreatment for osteoporosis. In patients who cannot tolerate or whose symptoms do not improve with bisphosphonate therapy, teriparatide (Forteo) and denosumab (Prolia) are effective alternative medications to prevent osteoporotic fractures